Voloridge Investment Management, LLC Amarin Corp Plcuk Transaction History

Voloridge Investment Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$3.24 - $5.18 $350,610 - $560,543	-108,213 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.94 - $5.84 $426,359 - $631,963	108,213 New	108,213 $552,000
Q4 2020 Feb 16, 2021	SELL	$4.04 - $5.31 $2.55 Million - $3.35 Million	-631,163 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$3.64 - $7.76 $4.25 Million - $9.06 Million	-1,166,990 Reduced 64.9%	631,163 $2.66 Million
Q2 2020 Aug 14, 2020	BUY	$4.78 - $8.26 $8.6 Million - $14.9 Million	1,798,153 New	1,798,153 $12.4 Million
Q2 2019 Aug 14, 2019	SELL	$16.27 - $20.51 $1.01 Million - $1.28 Million	-62,331 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$12.61 - $22.33 $785,993 - $1.39 Million	62,331 New	62,331 $1.29 Million

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $177M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.